Trinity Biotech plc (NASDAQ: NASDAQ:TRIB ) has captured market attention with a staggering 54.20% premarket surge on Tuesday, driven by robust demand for its TrinScreen HIV product. This significant price action reflects a positive shift in both the company's fundamentals and technical indicators, setting the stage for potential further gains. Let’s delve into...
Zigzag finished, guys. Time for a slip. Whether or not this is an even bigger zigzag in formation remains to be seen. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing...
someone please record these numbers, so we will decode it later, kkk odd numbers are happening. this means that something man-made is going on... kkk like dejavu in matrix trinity...
the only thing still holding us up is this trinity the moment it break, it's a disaster for the bulls, 51, 53, 55 is the support break that and dive to 25k, ;)
I've noticed the same pattern in bitcoin, but on a much much bigger timeframe. I'm going to call it the Trinity Pattern. I wonder how long will this last.
The stock price has been rising since a double bottom in early October. It broke out of a downtrend today with the price finding support on a level where the price gapped up. This area is also where the 200-EMA line is. Today's short float on this stock was 11.71%. Price targets are noted on the chart.
On the weekly timeframe we have a nice double Jesus Reversal Doji. The entire cryptospace was very toxic in the last year with its greed - a deadly sin. Many people who were in nice gains (including me) wanted still more more profit and their greed was growing parabolically with the price of BTC and other cryptos. God has warned us with this crypto crash and many...
reasons for the downmove: US Food and Drug Administration (FDA) had raised concerns over the Troponin device’s temperature range close facility in Sweden and move it to Ireland, which will reduce its cost base to US$1.5mln from US$9mln accounts will include a US$50mln write-off. cutting 40 jobs. Trinity will engage with the FDA for the approval being...